78 related articles for article (PubMed ID: 7697080)
1. After treatment ends: neutral time.
Hurt GJ; McQuellon RP; Barrett RJ
Cancer Pract; 1994; 2(6):417-20. PubMed ID: 7697080
[TBL] [Abstract][Full Text] [Related]
2. Fear of cancer recurrence--a literature review and proposed cognitive formulation to explain exacerbation of recurrence fears.
Lee-Jones C; Humphris G; Dixon R; Hatcher MB
Psychooncology; 1997 Jun; 6(2):95-105. PubMed ID: 9205967
[TBL] [Abstract][Full Text] [Related]
3. Canadian women's perspectives on ovarian cancer.
Fitch MI; Gray RE; DePetrillo D; Franssen E; Howell D
Cancer Prev Control; 1999 Feb; 3(1):52-60. PubMed ID: 10474753
[TBL] [Abstract][Full Text] [Related]
4. Experience and predictors of symptoms, distress and health-related quality of life over time in postmenopausal women with recurrent breast cancer.
Kenne Sarenmalm E; Ohlén J; Odén A; Gaston-Johansson F
Psychooncology; 2008 May; 17(5):497-505. PubMed ID: 17886259
[TBL] [Abstract][Full Text] [Related]
5. A qualitative evaluation of patient experiences when diagnosed with oral cancer recurrence.
Griffiths MJ; Humphris GM; Skirrow PM; Rogers SN
Cancer Nurs; 2008; 31(4):E11-7. PubMed ID: 18600106
[TBL] [Abstract][Full Text] [Related]
6. Post-therapy surveillance and after-care in ovarian cancer.
von Georgi R; Schubert K; Grant P; Münstedt K
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):228-33. PubMed ID: 15140520
[TBL] [Abstract][Full Text] [Related]
7. Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study.
van den Beuken-van Everdingen MH; Peters ML; de Rijke JM; Schouten HC; van Kleef M; Patijn J
Psychooncology; 2008 Nov; 17(11):1137-45. PubMed ID: 18484568
[TBL] [Abstract][Full Text] [Related]
8. Social support, anxiety and depression after chemotherapy for ovarian cancer: a prospective study.
Hipkins J; Whitworth M; Tarrier N; Jayson G
Br J Health Psychol; 2004 Nov; 9(Pt 4):569-81. PubMed ID: 15509362
[TBL] [Abstract][Full Text] [Related]
9. Mastectomy patients and the fear of cancer recurrence.
Northouse LL
Cancer Nurs; 1981 Jun; 4(3):213-20. PubMed ID: 6909039
[No Abstract] [Full Text] [Related]
10. Preoperative somatic symptoms are associated with disease progression in patients with bladder carcinoma after cystectomy.
Palapattu GS; Bastian PJ; Slavney PR; Haisfield-Wolfe ME; Walker JM; Brintzenhofeszoc K; Trock B; Zabora J; Schoenberg MP
Cancer; 2004 Nov; 101(10):2209-13. PubMed ID: 15476276
[TBL] [Abstract][Full Text] [Related]
11. Living with hope and fear--the uncertainty of childhood cancer after relapse.
De Graves S; Aranda S
Cancer Nurs; 2008; 31(4):292-301. PubMed ID: 18600116
[TBL] [Abstract][Full Text] [Related]
12. Attitudes to chemotherapy in patients with ovarian cancer.
Penson RT; Dignan F; Seiden MV; Lee H; Gallagher CJ; Matulonis UA; Olson K; Gibbens I; Gore ME
Gynecol Oncol; 2004 Aug; 94(2):427-35. PubMed ID: 15297184
[TBL] [Abstract][Full Text] [Related]
13. [Death education as a way to improve the quality of life of cancer patients after a relapse].
Deeken A
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():22-5. PubMed ID: 7747987
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in ovarian cancer patients receiving chemotherapy.
Lakusta CM; Atkinson MJ; Robinson JW; Nation J; Taenzer PA; Campo MG
Gynecol Oncol; 2001 Jun; 81(3):490-5. PubMed ID: 11371144
[TBL] [Abstract][Full Text] [Related]
15. Positive and negative affect after diagnosis of advanced cancer.
Voogt E; van der Heide A; van Leeuwen AF; Visser AP; Cleiren MP; Passchier J; van der Maas PJ
Psychooncology; 2005 Apr; 14(4):262-73. PubMed ID: 15386769
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
Mirabeau-Beale KL; Kornblith AB; Penson RT; Lee H; Goodman A; Campos SM; Duska L; Pereira L; Bryan J; Matulonis UA
Gynecol Oncol; 2009 Aug; 114(2):353-9. PubMed ID: 19481244
[TBL] [Abstract][Full Text] [Related]
17. Cancer fear and mood disturbance after radical prostatectomy: consequences of biochemical evidence of recurrence.
Ullrich PM; Carson MR; Lutgendorf SK; Williams RD
J Urol; 2003 Apr; 169(4):1449-52. PubMed ID: 12629381
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of ovarian cancer-living in limbo.
Ekwall E; Ternestedt BM; Sorbe B
Cancer Nurs; 2007; 30(4):270-7. PubMed ID: 17666975
[TBL] [Abstract][Full Text] [Related]
19. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
[TBL] [Abstract][Full Text] [Related]
20. Complete remission of platinium refractory ovarian cancer with second line tegafur with uracil monotherapy: a case report.
Camci C; Sevinc A; Aslan Y; Kalender ME; Buyukberber S
Cancer Chemother Pharmacol; 2009 Mar; 63(4):745-8. PubMed ID: 18504578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
